Pilot study on the use of fluorescence imaging of lymph nodes during laparoscopic pelvic sentinel node dissection for prostate cancer, using indocyanine green

Pilot study on the use of fluorescence imaging of lymph nodes during laparoscopic pelvic sentinel node dissection for prostate cancer, using indocyanine green - ICG sentinel node detection in prostate cancer

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

NL-OMON

Registry ID

NL-OMON33246

Enrollment

Registered

2009-12-15

Start date

2009-10-01

Completion date

Unknown

Last updated

2024-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

prostate cancer prostate carcinoma

Interventions

Preoperative transrectal ultrasound guided intraprostatic injection of a cocktail of ICG and NanoColl

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: - Histology proven prostate cancer - Increased risk of nodal metastases according to the MSKCC nomogram (>10%) - Scheduled for surgical (laparoscopic) resection

Exclusion criteria

Exclusion criteria: - History of allergy to iodides - Hyperthyroid or autonomic thyroidal adenoma - Kidney insufficiency

Design outcomes

Primary

Measure	Time frame
Feasibility of ICG fluorescence imaging in sentinel LN detection;	—

Secondary

Measure	Time frame
Matching ICG and gamma probe imaging	—

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)